Sampo Oyj Valuation
Is SAMPOH undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of SAMPOH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: SAMPOH (€39.94) is trading below our estimate of fair value (€59.89)
Significantly Below Fair Value: SAMPOH is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for SAMPOH?
Key metric: As SAMPOH is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is SAMPOH's PE Ratio? | |
|---|---|
| PE Ratio | 17x |
| Earnings | €1.27b |
| Market Cap | €21.61b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 2.5x |
| Enterprise Value/EBITDA | 11.7x |
| PEG Ratio | 2.8x |
Price to Earnings Ratio vs Peers
How does SAMPOH's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 9x | ||
ADM Admiral Group | 18.5x | 12.1% | UK£7.4b |
BEZ Beazley | 4.7x | -17.9% | UK£4.8b |
HSX Hiscox | 6.2x | -2.4% | UK£3.5b |
DLG Direct Line Insurance Group | 6.8x | 9.1% | UK£2.1b |
SAMPOH Sampo Oyj | 17x | 6.1% | €21.6b |
Price-To-Earnings vs Peers: SAMPOH is expensive based on its Price-To-Earnings Ratio (17x) compared to the peer average (9x).
Price to Earnings Ratio vs Industry
How does SAMPOH's PE Ratio compare vs other companies in the European Insurance Industry?
| 1 Company | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 1 Company | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: SAMPOH is expensive based on its Price-To-Earnings Ratio (17x) compared to the European Insurance industry average (12.1x).
Price to Earnings Ratio vs Fair Ratio
What is SAMPOH's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 17x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate SAMPOH's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | n/a | €43.82 0% | 7.7% | €51.00 | €38.00 | n/a | 16 |
| Nov ’25 | n/a | €43.66 0% | 7.9% | €51.00 | €38.00 | n/a | 16 |
| Oct ’25 | €41.87 | €42.88 +2.4% | 7.0% | €50.00 | €38.00 | n/a | 16 |
| Sep ’25 | €40.37 | €42.82 +6.1% | 6.3% | €48.00 | €38.00 | n/a | 16 |
| Aug ’25 | n/a | €43.12 0% | 7.0% | €49.00 | €38.00 | n/a | 15 |
| Jul ’25 | €39.90 | €43.18 +8.2% | 6.6% | €49.00 | €39.00 | n/a | 15 |
| Jun ’25 | n/a | €43.26 0% | 7.1% | €49.00 | €39.00 | n/a | 17 |
| May ’25 | n/a | €43.34 0% | 7.1% | €50.00 | €38.00 | n/a | 17 |
| Apr ’25 | n/a | €43.56 0% | 7.3% | €50.00 | €38.00 | n/a | 17 |
| Mar ’25 | n/a | €43.51 0% | 7.9% | €50.00 | €36.00 | n/a | 17 |
| Feb ’25 | n/a | €43.54 0% | 8.4% | €52.00 | €39.00 | n/a | 17 |
| Jan ’25 | n/a | €44.06 0% | 8.1% | €50.00 | €39.00 | n/a | 17 |
| Dec ’24 | €40.15 | €43.99 +9.6% | 8.0% | €50.00 | €39.00 | n/a | 17 |
| Nov ’24 | €37.35 | €44.24 +18.5% | 10.1% | €52.00 | €37.00 | n/a | 17 |
| Oct ’24 | n/a | €46.46 0% | 8.9% | €53.00 | €39.00 | €41.87 | 16 |
| Sep ’24 | n/a | €46.71 0% | 8.1% | €53.00 | €40.00 | €40.37 | 16 |
| Aug ’24 | €40.24 | €47.58 +18.2% | 10.2% | €58.00 | €40.00 | n/a | 17 |
| Jul ’24 | €41.15 | €48.39 +17.6% | 9.3% | €58.50 | €40.00 | €39.90 | 16 |
| Jun ’24 | €43.10 | €48.91 +13.5% | 5.8% | €53.00 | €45.00 | n/a | 14 |
| May ’24 | €45.48 | €49.47 +8.8% | 7.8% | €60.00 | €44.50 | n/a | 15 |
| Apr ’24 | €42.42 | €50.03 +18.0% | 7.1% | €60.00 | €45.00 | n/a | 16 |
| Mar ’24 | €46.12 | €50.37 +9.2% | 6.8% | €60.00 | €46.00 | n/a | 15 |
| Feb ’24 | €48.21 | €51.07 +5.9% | 6.8% | €60.00 | €46.00 | n/a | 15 |
| Jan ’24 | n/a | €50.21 0% | 7.7% | €60.00 | €43.00 | n/a | 15 |
| Dec ’23 | €48.27 | €49.44 +2.4% | 5.9% | €54.00 | €43.00 | €40.15 | 14 |
| Nov ’23 | €46.69 | €49.23 +5.4% | 6.7% | €54.00 | €43.00 | €37.35 | 15 |
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
Lancashire Holdings
UK£1.5b
Provides specialty insurance and reinsurance products in London, Bermuda, and Australia.
LREL
UK£6.23
7D
2.0%
1Y
-1.3%
Beazley
UK£4.8b
Provides risk insurance and reinsurance solutions in the United States, the United Kingdom, rest of Europe, and internationally.
BEZL
UK£7.65
7D
2.1%
1Y
38.9%
AXA
€68.0b
Through its subsidiaries, provides insurance, asset management, and banking services worldwide.
0HAR
€31.97
7D
-5.8%
1Y
12.4%